Utility of the mini-cog for detection of cognitive impairment in primary care: data from two spanish studies.

Q1 Neuroscience International Journal of Alzheimer's Disease Pub Date : 2013-01-01 Epub Date: 2013-08-28 DOI:10.1155/2013/285462
Cristóbal Carnero-Pardo, Isabel Cruz-Orduña, Beatriz Espejo-Martínez, Carolina Martos-Aparicio, Samuel López-Alcalde, Javier Olazarán
{"title":"Utility of the mini-cog for detection of cognitive impairment in primary care: data from two spanish studies.","authors":"Cristóbal Carnero-Pardo,&nbsp;Isabel Cruz-Orduña,&nbsp;Beatriz Espejo-Martínez,&nbsp;Carolina Martos-Aparicio,&nbsp;Samuel López-Alcalde,&nbsp;Javier Olazarán","doi":"10.1155/2013/285462","DOIUrl":null,"url":null,"abstract":"<p><p>Objectives. To study the utility of the Mini-Cog test for detection of patients with cognitive impairment (CI) in primary care (PC). Methods. We pooled data from two phase III studies conducted in Spain. Patients with complaints or suspicion of CI were consecutively recruited by PC physicians. The cognitive diagnosis was performed by an expert neurologist, after formal neuropsychological evaluation. The Mini-Cog score was calculated post hoc, and its diagnostic utility was evaluated and compared with the utility of the Mini-Mental State (MMS), the Clock Drawing Test (CDT), and the sum of the MMS and the CDT (MMS + CDT) using the area under the receiver operating characteristic curve (AUC). The best cut points were obtained on the basis of diagnostic accuracy (DA) and kappa index. Results. A total sample of 307 subjects (176 CI) was analyzed. The Mini-Cog displayed an AUC (±SE) of 0.78 ± 0.02, which was significantly inferior to the AUC of the CDT (0.84 ± 0.02), the MMS (0.84 ± 0.02), and the MMS + CDT (0.86 ± 0.02). The best cut point of the Mini-Cog was 1/2 (sensitivity 0.60, specificity 0.90, DA 0.73, and kappa index 0.48 ± 0.05). Conclusions. The utility of the Mini-Cog for detection of CI in PC was very modest, clearly inferior to the MMS or the CDT. These results do not permit recommendation of the Mini-Cog in PC. </p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"285462"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/285462","citationCount":"49","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Alzheimer's Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2013/285462","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/8/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Neuroscience","Score":null,"Total":0}
引用次数: 49

Abstract

Objectives. To study the utility of the Mini-Cog test for detection of patients with cognitive impairment (CI) in primary care (PC). Methods. We pooled data from two phase III studies conducted in Spain. Patients with complaints or suspicion of CI were consecutively recruited by PC physicians. The cognitive diagnosis was performed by an expert neurologist, after formal neuropsychological evaluation. The Mini-Cog score was calculated post hoc, and its diagnostic utility was evaluated and compared with the utility of the Mini-Mental State (MMS), the Clock Drawing Test (CDT), and the sum of the MMS and the CDT (MMS + CDT) using the area under the receiver operating characteristic curve (AUC). The best cut points were obtained on the basis of diagnostic accuracy (DA) and kappa index. Results. A total sample of 307 subjects (176 CI) was analyzed. The Mini-Cog displayed an AUC (±SE) of 0.78 ± 0.02, which was significantly inferior to the AUC of the CDT (0.84 ± 0.02), the MMS (0.84 ± 0.02), and the MMS + CDT (0.86 ± 0.02). The best cut point of the Mini-Cog was 1/2 (sensitivity 0.60, specificity 0.90, DA 0.73, and kappa index 0.48 ± 0.05). Conclusions. The utility of the Mini-Cog for detection of CI in PC was very modest, clearly inferior to the MMS or the CDT. These results do not permit recommendation of the Mini-Cog in PC.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
mini-cog在初级保健中检测认知障碍的效用:来自两项西班牙研究的数据。
目标。目的:探讨Mini-Cog试验在初级保健(PC)患者认知功能障碍(CI)检测中的应用价值。方法。我们汇集了在西班牙进行的两项III期研究的数据。主诉或怀疑CI的患者由PC医师连续招募。认知诊断是在正式的神经心理学评估后由一位神经专家进行的。事后计算Mini-Cog评分,评估其诊断效用,并与Mini-Mental State (MMS)、Clock Drawing Test (CDT)和MMS与CDT的总和(MMS + CDT)的效用进行比较,采用受试者工作特征曲线下面积(AUC)。根据诊断准确度(DA)和kappa指数确定最佳切点。结果。共分析307例受试者(176 CI)。Mini-Cog的AUC(±SE)为0.78±0.02,明显低于CDT(0.84±0.02)、MMS(0.84±0.02)和MMS + CDT(0.86±0.02)的AUC。Mini-Cog的最佳切割点为1/2(敏感性0.60,特异性0.90,DA 0.73, kappa指数0.48±0.05)。结论。Mini-Cog在PC中检测CI的效用非常有限,明显不如MMS或CDT。这些结果不允许在PC中推荐Mini-Cog。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Alzheimer's Disease
International Journal of Alzheimer's Disease Neuroscience-Behavioral Neuroscience
CiteScore
10.10
自引率
0.00%
发文量
3
审稿时长
11 weeks
期刊最新文献
Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer's Disease. Advancements and Challenges in Antiamyloid Therapy for Alzheimer's Disease: A Comprehensive Review. Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1